SEC Form 4 · accession 0001209191-18-041870
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julia R Brown
Director
Period of report
Jun 7, 2018
Accepted (ET)
Jul 6, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 7, 2018 | M | 3,333 | $9.00 | A | 7,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.00 | Jun 7, 2018 | M | 3,333 | D | — | Feb 23, 2023 | Common Stock | 3,333 | 0 | D |
Explanation of responses
- F1All shares underlying this option have vested.